Explorer

DeepMind's CEO On How AI Will Make Drug Discovery Faster Than Ever

Demis Hassabis, the head of Google's DeepMind, believes AI will soon revolutionise medicine, accelerating the drug discovery process from years to a matter of months.

Finding new medicines usually takes many years and often ends in failure. But Demis Hassabis, the Nobel Prize-winning head of Alphabet’s AI arm DeepMind, thinks this can change with artificial intelligence. He said drug discovery may soon take months instead of years. This could mean patients get new treatments faster and at lower costs, as reported by Bloomberg.

Hassabis, who also leads Alphabet’s Isomorphic Labs, said the tools built by DeepMind are now ready to move from research into real medical use.

AI Could Cut Time From Years To Months

Hassabis runs Google DeepMind and also leads Isomorphic Labs, a drug discovery division created in 2021. Since its launch, Isomorphic Labs has signed deals with Eli Lilly & Co. and Novartis AG.

Bloomberg reported that the company is using AlphaFold, an AI tool that predicts protein behaviour, to help design new drugs. Hassabis and fellow scientist John Jumper won the 2024 Nobel Prize in chemistry for their work on this technology.

The company is now developing a more advanced version of AlphaFold that can study more than just protein interactions. Earlier this year, Isomorphic Labs raised $600 million, led by Thrive Capital and is now valued at over $100 billion, according to Hassabis.

The lab is working on treatments for cancer and immune system disorders, with early results showing “good progress.”

First Steps And What’s Next

Even though AI has shown promise in analysing complex molecular data, no AI-designed drug has yet completed a successful clinical trial. Hassabis earlier said clinical testing could begin by the end of this year, but the timeline remains unclear. “It’s a bit early to say,” he admitted.

Rebecca Paul, director of medicinal drug design at Isomorphic Labs, added that AI could eventually turn many cancers into treatable chronic illnesses. While the timing is uncertain, she said the progress so far is encouraging.

About the author Annie Sharma

Annie Sharma is a technology journalist at ABP Live English, focused on breaking down complex tech stories into clear, reader-friendly narratives. Gaining hands-on experience in digital storytelling and news writing with leading publications, Annie believes technology should feel accessible rather than overwhelming, and follows a clear, reader-first approach in her work.

For tips and queries, you can reach out to her at annies@abpnetwork.com.

Read

Top Headlines

Iran Warns Neighbours After Trump Threats, Says US Bases Could Be Targeted
Iran Warns Neighbours After Trump Threats, Says US Bases Could Be Targeted
Trump’s Big Decision: US To Deny Visas To 75 Countries-Is India Or Pakistan On The List?
Trump’s Big Decision: US To Deny Visas To 75 Countries-Is India Or Pakistan On The List?
Banned Chinese Kite Strings Turn Deadly: Two Killed, Nationwide Safety Concern Grows
Banned Chinese Kite Strings Turn Deadly: Two Killed, Nationwide Safety Concern Grows
Zubeen Garg Was Drunk, Declined Life Jacket Before Drowning: Singapore Police To Court
Zubeen Garg Was Drunk, Declined Life Jacket Before Drowning: Singapore Police To Court

Videos

Breaking: Delhi Government Expands Ayushman Arogya Mandir Network to 319 Centres
Breaking: Joint Police Operation Busts Major Drug Racket in Madhya Pradesh, 10 Kg Narcotics Seized
Breaking: Calcutta High Court Tightens Security Ahead of ED–I-PAC Raid Hearing, Only Case Lawyers Allowed
Breaking: Tej Pratap Yadav Hosts Dahi Chura Bhoj in Patna, Lalu Prasad and Governor Attend Amid Political Speculations
Breaking: Pakistani Drones Spotted Near LoC in Jammu and Kashmir, Indian Army on High Alert

Photo Gallery

25°C
New Delhi
Rain: 100mm
Humidity: 97%
Wind: WNW 47km/h
See Today's Weather
powered by
Accu Weather
Embed widget